Australia Pharmaceutical Contract Development And Manufacturing Organization Market Size & Outlook
Related Markets
Australia pharmaceutical contract development and manufacturing organization market highlights
- The Australia pharmaceutical contract development and manufacturing organization market generated a revenue of USD 3,137.7 million in 2024 and is expected to reach USD 6,346.7 million by 2033.
- The Australia market is expected to grow at a CAGR of 8.2% from 2025 to 2033.
- In terms of segment, small molecule was the largest revenue generating type in 2024.
- Small Molecule is the most lucrative type segment registering the fastest growth during the forecast period.
Pharmaceutical contract development and manufacturing organization market data book summary
| Market revenue in 2024 | USD 3,137.7 million |
| Market revenue in 2033 | USD 6,346.7 million |
| Growth rate | 8.2% (CAGR from 2025 to 2033) |
| Largest segment | Small molecule |
| Fastest growing segment | Small Molecule |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, Australia accounted for 2.0% of the global pharmaceutical contract development and manufacturing organization market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China pharmaceutical contract development and manufacturing organization market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 39,514.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Contract Development And Manufacturing Organization Market Scope
Pharmaceutical Contract Development And Manufacturing Organization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Recipharm AB | View profile | - | - | - |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| ThermoGenesis Holdings Inc | View profile | 25 | 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 | https://www.thermogenesis.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Australia pharmaceutical contract development and manufacturing organization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 82.8% in 2024. Horizon Databook has segmented the Australia pharmaceutical contract development and manufacturing organization market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Australia pharmaceutical contract development and manufacturing organization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia pharmaceutical contract development and manufacturing organization market databook
-
Our clientele includes a mix of pharmaceutical contract development and manufacturing organization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia pharmaceutical contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Australia pharmaceutical contract development and manufacturing organization market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Type - Pharmaceutical Contract Development And Manufacturing Organization Market size, 2024 - 2033 (US$M)
Australia Pharmaceutical Contract Development And Manufacturing Organization Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
